FCS has a national reputation for excellence that is reflected in exceptional and compassionate patient care, innovative clinical research, cutting-edge technologies, and advanced treatments. With nearly 100 locations, FCS serves patients throughout Florida. we are committed to providing world-class cancer care in community-based settings close to home.
FDA grants accelerated approval to camizestrant for ESR1-mutated HR+/HER2- metastatic breast cancer. Learn how FCS research helped lead to this new therapy.
Many people cut sugar from their diet believing it will stop cancer from growing or spreading, but the relationship between sugar and cancer is far more complex.